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ABSTRACT
Introduction: Evidence from observational studies and
randomised controlled trials suggests that
breastfeeding is positively associated with IQ, possibly
because breast milk is a source of long-chain
polyunsaturated fatty acids. Different studies have
detected gene-breastfeeding interactions involving
FADS2 variants and intelligence. However, findings are
inconsistent regarding the direction of such effect
modification.
Methods/design: To clarify how FADS2 and
breastfeeding interact in their association with IQ, we
are conducting a consortium-based meta-analysis of
independent studies. Results produced by each
individual study using standardised analysis scripts
and harmonised data will be used. Inclusion criteria:
breastfeeding, IQ and either rs174575 or rs1535
polymorphisms available; and being of European
ancestry. Exclusion criteria: twin studies; only poorly
imputed genetic data available; or unavailability of
proper ethics approval. Studies will be invited based on
being known to have at least some of the required
data, or suggested by participating studies as
potentially eligible. This inclusive approach will favour
achieving a larger sample size and be less prone to
publication bias.
Discussion: Improving current understanding of
FADS2-breastfeeding interaction may provide important
biological insights regarding the importance of long-
chain polyunsaturated fatty acids for the breastfeeding-
IQ association. This meta-analysis will help to improve
such knowledge by replicating earlier studies,
conducting additional analysis and evaluating different
sources of heterogeneity. Publishing this protocol will
minimise the possibility of bias due to post hoc
changes to the analysis protocol.
INTRODUCTION
Consortium-based efforts have been pro-
posed as a practice that may contribute to
generate more reliable scientiﬁc ﬁndings.1
Such an approach has many desirable
characteristics, including improved power by
increasing sample size, harmonisation of vari-
ables and analyses, and avoiding winner’s
curse bias. Adapting a similar approach used
in a previous work on 5-HTTLPR, stress and
depression,2 this manuscript describes the
protocol for a collaborative meta-analysis on
the interaction between breastfeeding and
FADS2 polymorphisms when IQ is the
outcome. As described previously,2 publish-
ing the protocol is important for several
reasons. These include: avoiding biased
reporting by documenting study protocol
and design, as well as primary analysis, prior
to conducting and publishing the study;
facilitate the understanding of the results of
the study by its readership when it is com-
pleted; and help similar initiatives in the
future to elaborate a protocol and encourage
this practice as a means to improve transpar-
ency and commitment to the analysis plan
deﬁned a priori.
BACKGROUND
There is substantial evidence of short-term
health beneﬁts of breastfeeding by reducing
Strengths and limitations of this study
▪ Standardised statistical analysis of harmonised
data will improve comparability between studies.
▪ Attempts to include both published and unpub-
lished studies will minimise the possibility of
publications bias.
▪ It will not be possible to fully harmonise expos-
ure and outcomes measures.
▪ Additional sources of heterogeneity will likely
remain.
▪ Elaborating and reporting the analytical plan
before data analysis will protect against biased
reporting.
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children morbidity and mortality from infectious dis-
eases.3 4 Basing on this evidence, WHO5 and the United
Nations Children’s Fund6 recommend that every child
should be exclusively breastfed for 6 months, with partial
breastfeeding continued until 2 years. More recently, asso-
ciations between breastfeeding and positive health out-
comes in adulthood suggest that breastfeeding might also
have long-term effects.4 7–9
Different epidemiological studies have detected posi-
tive associations between breastfeeding and
intelligence-related outcomes.7 9 Residual confounding
has been suggested to inﬂuence much of the ﬁndings
involving breastfeeding and child cognitive develop-
ment.10 However, randomised trials provided evidence
that breastfeeding causes increased motor development
during the ﬁrst year of life,11 as well as intelligence mea-
sured in healthy infants participating in the Promotion
of Breastfeeding Intervention trial.12 Additional evi-
dence of health beneﬁts of breastfeeding from rando-
mised studies includes better cardiovascular risk proﬁle
(lipoprotein proﬁle13 and blood pressure14) in preterm-
born children at 13–16 years. Long-term observational
associations with IQ have also been detected. For
example, a recent population-based study in South
Brazil (where breastfeeding is not associated with socio-
economic position at birth) identiﬁed a positive associ-
ation with IQ in individuals aged 30–31 years; this
association captured 72% of the association of breast-
feeding with income.15 This raises the possibility that
breastfeeding not only inﬂuences health, and also intel-
lectual human capital and economic productivity.15
Given the nature of the interventions in some of the
aforementioned trials,13 14 at least some of the effects of
breastfeeding are hypothesised to be biological. Regarding
intelligence, a potential mechanism is that breast milk is a
source of long-chain polyunsaturared fatty acids
(LC-PUFAs) including docosahexaenoic acid (DHA),
which have been implicated in brain development.16 17 It
has been hypothesised that the association between breast-
feeding and IQ could differ according to the capacity to
synthetise DHA from metabolic precursors.18 Special
attention has been given to genetic variation in the FADS2
gene, which encodes a protein involved in desaturation
processes required for endogenous synthesis of LC-PUFAS
from shorter chain fatty acids.19 20
Caspi and colleagues provided evidence for
FADS2-breastfeeding interaction involving two FADS2 var-
iants: rs174575 (major/minor allele: C/G) and 1535
(major/minor allele: A/G). In two independent
samples, breastfeeding was positively associated with IQ
in non-G carriers, but not in GG individuals.18 However,
these results were not in accordance with the DHA
hypothesis, since rs174575 -G allele has been associated
with lower LC-PUFAs levels in serum21 and plasma22 in
large studies, although smaller (and possibly underpow-
ered) studies failed to detect such associations.23 24
Therefore, GG individuals would be expected to beneﬁt
more from breastfeeding than their counterparts.
Indeed, a subsequent FADS2-breastfeeding interaction
study using a larger sample obtained results consistent
with this hypothesis, with the strongest association occur-
ring in GG individuals.20 On the other hand, three twin
studies failed to detect any interaction.25–27 One of them
failed to demonstrate a dose-response trend.25 Another
study observed a negative trend between breastfeeding
and IQ at age 18 years, but CIs were large, and the same
trend was not observed for educational attainment at
age 12 years.26
There may be several heterogeneity sources that will be
discussed below:
1. Study design: Several design aspects can inﬂuence
results. One such aspect is sample size, and publica-
tion bias is due to the selective publication of small
studies with positive results. Sample size is particularly
important for this meta-analysis because the ongoing
debate relates to the association of breastfeeding and
IQ among GG individuals (minor allele homozy-
gotes), which prevalence is expected to be ∼12.9%
(rs1535) and 7.2% (rs174575) in European ancestry
samples based on estimates from the 1000 Genomes
Project (phase 3).
Another issue is that several of the published studies
collected breastfeeding information retrospectively at
different offspring ages (2 years,26 2–3 years,18 10
years,27 12 or 16 years,25 and 5–33 years26), while one
study used prospective data.20 Retrospective measure-
ments might be subjected to recall bias. We will evalu-
ate the role of study design characteristics as sources
of heterogeneity.
2. Sample characteristics: General sample characteristics
may inﬂuence the results due to non-modelled inter-
actions or different confounding structures. For
example, a cross-cohort comparison evidenced that
the association between breastfeeding and socio-
economic position is different between the British
Avon Longitudinal Study of Parents and Children
(from a high-income population) and the Brazilian
1993 Pelotas Birth Cohort (from a middle-income
population).28 Another important aspect is ethnicity
because genetic epidemiology studies in multiethnic
samples are subjected to bias from population stratiﬁ-
cation.29 Moreover, samples from different ethnicities
may differ regarding underlying linkage disequilib-
rium structure. In case of indirect association, this
could introduce heterogeneity due to differential
associations between the genotyped variant(s) with
the causal variant(s) between ethnicities.30
Another point related to both sample characteristics
and study design is twin studies. Systematic differ-
ences in breastfeeding have been observed when
comparing singletons and twins,31 32 which could
limit the comparability of results. We therefore opted
by limiting the meta-analysis to singletons of
European ancestry. We will also investigate the contri-
bution of other sample characteristics to between-
study heterogeneity.
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3. Limited breastfeeding information: In addition to breast-
feeding prevalence, other factors such as duration
and quality (eg, exclusive vs non-exclusive) are
important when studying the association of breast-
feeding with any outcome of interest. Owing to all
FADS2-breastfeeding interaction studies published so
far having used breastfeeding as a binary (never vs
ever breastfed), important information is likely being
lost. For example, it is not possible to do a fair com-
parison using a binary breastfeeding variable when
the samples greatly differ regarding average breast-
feeding duration.
On the other hand, using three or more categories
of breastfeeding may incur in power issues when
evaluating interactions. Therefore, we will use (when-
ever available) more detailed breastfeeding data to
gain insights such as whether there is a dose-response
pattern given that power issues are likely to be
reduced. We will also evaluate whether breastfeeding
characteristics (eg, prevalence and duration) contrib-
ute to heterogeneity.
4. Timing and nature of IQ measurements: The aforemen-
tioned studies measured IQ using different tests or
comprising different subtests and at different ages.
These are potential sources of heterogeneity, which
will be explored in our analysis. To improve numerical
comparability across studies, IQ measurements will be
converted to sample-speciﬁc Z-scores prior to analysis.
Study objectives
The general aim of our study is to contribute to clarify
how FADS2 variants and breastfeeding interact regarding
their association with IQ. We will address this research
question by conducting a collaborative meta-analysis
using results from de novo standardised analyses per-
formed by collaborators using variables determined
before data analysis.
Our study will test the following main hypotheses:
1. The association between breastfeeding and IQ is dif-
ferent among GG individuals compared to non-G
carriers.
2. Using more detailed breastfeeding data rather than a
dichotomous variable will provide additional insights
(eg, whether or not a dose-response relationship exists).
3. Factors associated with study design or sample
characteristics are sources of between-study
heterogeneity.
It is possible that a posteriori hypotheses based on
exploratory analysis emerge. In case they occur, they will
be clearly indicated as such when reporting results.
METHODS/DESIGN
Overview
The coordinating team deﬁned the analytical plan,
inclusion criteria and variables to be analysed a priori.
The overall guideline for such deﬁnition was to properly
replicate previous investigations based on a binary
variable for breastfeeding (eg,18 and20), as well as includ-
ing additional analyses (eg, evaluation of dose–
response), while adjusting for important potential
confounders.
As previously described,2 using de novo results in a
collaborative meta-analysis has several desirable aspects.
These include analysis of harmonised data using consist-
ent analytical approaches (such as statistical tests and
covariate adjustment), inclusion of unpublished data
and possibility of performing secondary analysis.
Statistical analysis of each individual study will be per-
formed by its own investigators using standardised
scripts developed by the coordinating team. A detailed
analysis plan describing how to use the scripts provided,
and how they work, will be distributed to the analysts.
Eligibility criteria
Studies will be considered eligible for this study if they
meet all the following criteria:
1. Data availability. The minimal data required for eligi-
bility is:
▸ Binary (never vs ever) breastfeeding variable
(either any or exclusive breastfeeding);
▸ IQ measured using standard tests;
▸ At least one of the two FADS2 polymorphisms con-
sidered: rs174575 and rs1535—both genotyped
and imputed will be included.
2. Ancestry. To avoid population stratiﬁcation and ances-
try effects, only samples of European ancestry are eli-
gible. Multiethnic studies will be eligible if they can
identify a subsample of European ancestry. Whenever
possible, such classiﬁcation will be based on
ancestry-informative principal components (see
‘Study variables’ for details), although other indica-
tors (eg, self-reported skin colour) will also be
considered.
3. Study design. Prospective and retrospective cohort
studies will be included.
Exclusion criteria for this study are:
1. Genetic data. The only genetic data available is
imputed, and its imputation quality (eg, r² and INFO
metrics of MACH and IMPUTE, respectively33) is
below 0.3.
2. Study design. Twin studies will not be included.
3. Ethical issues. Studies that do not have appropriate
ethical approval to use their data as this study
requires will be excluded.
Identifying studies
Our aim is to invite all eligible studies to participate,
regardless of having published or not on this topic.
Doing so will favour the achieving of a larger sample size
and minimise publication bias. Invitations will be sent to
groups that are known by the coordinating team to have
at least some of the data required available, and sug-
gested by participating groups as possibly eligible.
Although this approach is likely unspeciﬁc (ie, we
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expect that some of the contacted studies are not eli-
gible), it is useful for improving sensitivity.
Following an initial contact, the analysis plan will be
distributed to studies interested in participating. This
has two main goals: identify eligible studies and obtain
feedback regarding the analysis plan. One or more indi-
vidual studies will be invited to run preliminary analysis
using the code developed by the coordinating team in
order to identify and correct potential issues before dis-
tributing the code to all contributing studies.
Study variables
1. Breastfeeding. The simplest form will be as a binary
variable (never vs ever breastfed). Whenever breast-
feeding duration is available, four additional breast-
feeding variables will be considered: binary
(<6 months and ≥6 months) categorical (none, >0
and ≤1, >1 and ≤3, >3 and ≤6 months and >6
months), numerically coded categorical (for linear
trend tests) or numeric (in months) variable. For
studies with information regarding breastfeeding
quality (ie, any vs exclusive), all breastfeeding vari-
ables will be generated twice, corresponding to each
quality category.
2. IQ. Different IQ measures that yield an approxi-
mately normally distributed numerical variable will
be included. To improve numerical comparability,
such measures will be converted to sample Z-scores
(ie, for each observation, subtract the mean and
divide by the SD). However, this does not imply in
comparability regarding other aspects, such as type of
test or subtests included. Since limiting based on
such aspects would be too restrictive, we opted by
being less stringent in this regard. The inﬂuence of
such differences will be evaluated at the meta-analysis
stage.
3. FADS2 polymorphisms. We will use two single nucleo-
tide polymorphisms (SNPs) in the FADS2 gene:
rs174575 and rs1535. Each SNP is a three-level vari-
able, depending on how many copies an individual
carries of the rarest (G) allele. The levels are: no
copies of the G allele (ie, two copies of the major
allele); one copy of the G allele and one copy of the
major allele (heterozygous), and two copies of the G
allele (ie, homozygous G). The genotypes corre-
sponding to each of these levels are CC, CG and GG
for rs174575; and AA, AG and GG for rs1535.
G is expected to be the rarest allele in Europeans
samples, with a frequency of about 25.5% and 35.0%
for rs174575 and rs1535, respectively. Importantly,
since C pairs with G, strand-orientation issues related
to the rs174575 variant can only be detected by com-
paring observed with expected allele frequencies. As
a quality control check, the analysis script will stop if
the G-allele frequency is outside the range of 10–
40%. Both genotyped and imputed SNPs will be con-
sidered. If imputed, dosages corresponding to the G
allele rather than ‘best-guess’ genotypes will be used.
Each polymorphism will be coded in four different
forms, reﬂecting distinct genetic effects: additive or
per-allele, corresponding to the number of copies of
the G allele (AA or CC=0, AG or CG=1, GG=2); dom-
inant, where G-allele carriers are compared to
non-G-carriers (AA or CC=0, AG/GG or CG/GG=1);
recessive, where GG individuals are compared with
A-allele or C-allele carriers (AA/AG or CC/CG=0,
GG=1); and overdominant, where heterozygous are
compared with homozygous individuals (AA/GG or
CC/GG=0, AG or CG=1).
4. Covariates. This study will include the following
covariates:
▸ Sex (male/female).
▸ Age at IQ measurement (in years) and age2
(to account for potential non-linear age effects).
▸ Ancestry-informative principal components34 for
studies with genome-wide genotyping data available.
Such components (calculated within the European
subsample using a subset of independent SNPs of
minor allele frequency >1%) will be used to account
for residual population stratiﬁcation.
▸ Measures of maternal education or maternal cog-
nition. To achieve international comparability,
maternal education will be coded according to
the 1997 International Standard Classiﬁcation of
Education (ISCED) of the United Nations
Educational, Scientiﬁc and Cultural
Organization.35 To improve numerical compar-
ability across studies (relevant to sensitivity ana-
lysis), maternal cognition will be converted to
sample Z-scores. In studies that measured these
variables more than once (ie, at different time
points), the closest time point to offspring birth
will be used. Adjusting for these variables will be
performed similarly to age at IQ measurement to
account for potential non-linear effects.
▸ A categorical indicator of ﬁeld centre for multi-
centric studies. This will be used to account for
eventual batch effects.
▸ Any other recommended study-speciﬁc indicators,
if considered necessary by the coordinating team.
Statistical analysis
1. Overview and preanalysis steps: The scripts were written
in R (http://www.r-project.org) due to its free avail-
ability and widespread use. Two scripts were produced.
One is called ‘user’s script’ and is aimed at being used
by the analysts. It contains <200 lines of code, and the
vast majority are comment lines explaining how to
conduct each step with examples. The other is called
‘developer’s script’, which contains the actual func-
tions that will perform quality control checks, calcu-
late summary statistics and perform association
analysis in >1000 lines of code. By providing a simpli-
ﬁed script that uses more complicated functions from
an accompanying script, we hope to reduce the work
burden of contributing studies.
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To ensure consistency across studies, only the coord-
inating team will make any eventual modiﬁcations in
the developer’s script. So, in case an analyst identiﬁes
an issue, it will be reported to the coordinating team
who will make any revisions if necessary, and redistrib-
ute the code.
The main task of the analysts will be to format the
data for the analysis. The analysis plan will contain
detailed instructions on how the data should be for-
matted. To minimise harmonisation issues, the ﬁrst
step of the analysis will be a series of quality control
checks regarding general data formatting, eligibility
criteria, categorical variable levels, outliers (deﬁned as
being outside the range of ±4 SDs from the mean)
and impossible numbers (eg, negative IQ points) in
continuous variables. After the quality control step,
summary statistics for the sample and for the SNPs will
be generated. These will be used at the meta-analysis
stage to identify potential heterogeneity sources.
2. Association analysis: Association analysis will be per-
formed by linear regression with heteroskedasticity
robust SEs. The main statistical model underlying all
analysis is
IQ = b0þb1BF +b2FADS2 +b3ðBFFADS2)
þ
Xnþ3
i¼4 bicovi3þ
X2nþ3
i¼nþ4 biðBFcovi3nÞ
þ
X3nþ3
i¼2nþ4 biðFADS2covi32nÞ;
where:
BF: breastfeeding (any or exclusive) as a binary, categor-
ical, numerically coded categorical variable or numeric
(in months) variable;
FADS2: FADS2 polymorphism (rs174575 or rs1535)
coded in additive or recessive model;
cov: generic representation of a covariate;
n: number of covariates included in the analysis.
Given that all analysis will be performed three times
(unadjusted and two adjusted models), up to 240 regres-
sion analyses will be performed. For studies that meet
the minimal eligibility criteria, this number will be 12.
The potential confounding effect of covariates on the
interaction between breastfeeding and FADS2 will be
properly modelled by including interaction terms of
breastfeeding and FADS2 polymorphism with each
covariate.36
3. The primary analysis will use any breastfeeding in
binary form and a recessive genetic model in
unadjusted and adjusted models. This corresponds to
a replication of the main analysis performed by Caspi
et al18 and Steer et al20 The remaining analyses are
aimed at further exploring the FADS2-breastfeeding
interaction by evaluating different genetic models,
and whether or not there are dose-response breast-
feeding effects. Covariate adjustment; regarding cov-
ariate adjustment, three analyses will be performed:
▸ Unadjusted (model 1);
▸ Adjusted for sex, age and age2. Multicentric
studies or studies with genome-wide genotyping
data available will also control for ﬁeld centre or
ancestry-informative principal components,
respectively (model 2);
▸ Adjust for the same covariates listed above, and
also for maternal education and (maternal educa-
tion)², and/or maternal cognition and (maternal
cognition)2 (model 3).
4. Meta-analysis: Descriptive statistics will be checked for
potential errors which will be corrected before con-
ducting the meta-analysis. We will then conduct a pre-
liminary analysis to evaluate if there is heterogeneity
due to a few studies; if so, the coordinating team will
contact these studies individually for identiﬁcation of
potential errors or problems. In case no issues are
identiﬁed, the study(ies) will be included in the
meta-analysis.
After checking for these potential sources of artiﬁ-
cial heterogeneity, we will then conduct the ﬁnal
meta-analysis. We will report both ﬁxed-effects and
random-effects, and use meta-regression to evaluate
the following sources of heterogeneity: age, preva-
lence and duration of breastfeeding, retrospective
versus prospective breastfeeding information, mea-
sures of IQ, adjustment for principal components
and continental region. The main statistics that we
will report are the pooled linear regression coefﬁ-
cients for breastfeeding (corresponding to the
effect among individuals in the baseline FADS2
genotype), FADS2 (corresponding to the effect
among individuals never breastfed) and
FADS2-breastfeeding interaction. We will also report
heterogeneity statistics and subgroup-speciﬁc esti-
mates, as well as descriptive statistics from each
contributing study.
5. Sensitivity analysis: We will compare overall
meta-analytical estimates with results obtained using
subsets of all studies. In case heterogeneity is
detected, we will also report estimates for homoge-
neous subgroups in order to understand if some
sources of heterogeneity could be attributed to bias.
For example, subsetting based on sample size or
length of recall of information on breastfeeding dur-
ation may yield insights on the inﬂuence of publica-
tion or recall bias (respectively) in the estimates.
To explore the possibility of bias due to gene–envir-
onment correlation, we will repeat FADS2-breastfeed-
ing interaction analysis having maternal education
(converted to US years of education based on ISCED
standards, as reported previously37) and maternal
cognition as the outcome variable. Since only models
1 and 2 will be performed for these outcomes, there
will be 160 regression analyses for each. Added to the
240 analyses for IQ, de novo results from 560 regres-
sion analyses (performed automatically by the scripts
provided) will be obtained from studies that contrib-
ute to all analyses.
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Sample size calculation
Sample size requirements to detect a FADS2-breastfeed-
ing interaction were evaluated through simulations
(5000 simulations per combination of parameters) using
R V.3.2.4.
The following parameters were evaluated:
A. Prevalence of ever being breastfed: 85% and 95%.
These values are based on the estimates recently pro-
vided by Victora et al4 for high-income countries and
for countries in all other income groups, respectively.
B. Prevalence of the GG genotype: 7.2% and 12.9%.
These values were obtained from the 1000 Genomes
(phase 3) Project Browser for the rs174575 and
rs1535 SNPs (respectively) in European populations.
C. Mean difference in IQ according to FADS2 poly-
morphism among individuals never breastfed, com-
paring GG individuals with non-G carriers: −2.15,
−4.3 and −8.6. The intermediate value (−4.3) corre-
sponds to the results from Steer et al20 which is the
largest study that evaluated the FADS2-breastfeeding
interaction on IQ to date. The remaining values cor-
respond to half and twice the effect reported by
Steer et al, and were used to evaluate sample size
requirements in case of weaker and stronger FADS2
effects.
D. Mean difference in IQ according to FADS2 poly-
morphism among ever breastfed individuals: zero
and half the effect in the never breastfed group.
Lack of FADS2 effect among ever breastfed indivi-
duals correspond to the DHA hypothesis described
above.
E. Sample size (10 000, 12 500, 15 000, 17 500 and
20 000 individuals).
All possible combinations of the above parameters cor-
respond to 120 simulation scenarios. In all of them, the
outcome variable was normally distributed (mean=100
and SD=10) and FADS2 and breastfeeding were inde-
pendent. p Values for the interaction coefﬁcient were
obtained from linear regression models (two-sided
t tests). Power was deﬁned as the proportion of tests
with p<0.05.
Among the 120 simulation scenarios, power was <80%
in only seven of them. The most critical scenario was
when breastfeeding prevalence was 95%, GG prevalence
was 7.2%, FADS2 effect among individuals never breast-
fed was −2.15, and the effect among ever breastfed indi-
viduals was half the latter (power=77.3% for a sample
size of 20 000 individuals). When sample size was up to
12 500 individuals, power was also <80% when GG preva-
lence was 12.9%.
It is important to consider that none of the scenarios
were underpowered when breastfeeding prevalence was
85%. This estimate is likely to apply to this study better
than the value of 95% given that our focus is on indivi-
duals of European ancestry (therefore, samples from
high-income countries are more likely to be eligible).
Moreover, none of the scenarios was underpowered
when FADS2 effect was at least equal to the effect
reported by Steer et al (which is the best estimate cur-
rently available), as well as when there was no FADS2
effect among ever breastfed individuals.
Therefore, in the majority of realistic scenarios, a
sample size of 10 000 individuals would allow properly
powered primary analysis. On the basis of a preliminary
identiﬁcation of eligible studies, achieving such sample
size is feasible.
Ethics statement
Only studies with appropriate ethical approval will be con-
sidered to participate. Only summary-level statistics (rather
than individual-level data) will be shared between the indi-
vidual study and the coordinating team. Therefore, the
present study does not require additional ethical approval
other than what has already been provided to participating
studies individually. We will obtain all necessary institu-
tional approvals to conduct the analysis.
DISCUSSION
This collaborative meta-analysis has the potential to
improve the understanding of the effect modiﬁcation of
FADS2 variants on the association between breastfeeding
and IQ. However, the study has some limitations.
To achieve a larger sample size and allow participation
of different studies, some compromises are necessary.
Particularly, we will include breastfeeding measures with
different recall times, as well as IQ measures that differ
regarding test, subtests included and/or age at measure-
ment. Although a large sample size will contribute to
minimise limitations due to heterogeneity (which will
also be evaluated in detail), such inconsistencies might
still inﬂuence the results.
Second, the analysis will be limited to singletons of
European ancestry. This will likely reduce heterogeneity
(eg, due to systematic differences in breastfeeding pat-
terns comparing twins with singletons), and bias (eg, due
to population stratiﬁcation). Moreover, most genetic epi-
demiology studies to date have been conducted in
Europeans, so it is unlikely that restricting this to
Europeans will incur substantial sample size losses.
However, it may limit the external validity of our ﬁndings.
Third, several heterogeneity tests will be performed.
However, it is difﬁcult to identify all potential sources of
heterogeneity. Moreover, it may occur that, in some cases,
subsetting studies based on heterogeneity-associated
factors result in small subgroups, thus yielding imprecise
subgroup-speciﬁc estimates.
Fourth, availability of maternal education or maternal
cognition measures was not included as one eligibility
criterion. Although we recognise the importance of
accounting for these variables in studies involving breast-
feeding and IQ, we opted by allowing studies without
these data to participate for two main reasons. First, it is
likely that requiring these data would substantially
reduce the sample size. Second, previous publications
observed no major implication of such measures on
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FADS2-breastfeeding interaction.18 20 Therefore, we
opted for an inclusive approach coupled with sensitivity
analyses using the subset of studies with these data.
Finally, based on sample size calculations under a variety
of realistic situations, we expect to have enough power to
detect interaction effects. However, a lack of strong statis-
tical association could be a result of small effects and/or
heterogeneity that we fail to account for. Moreover, given
the inconsistencies among published studies and the fact
that we will properly control for confounding in the inter-
action setting, it is also possible that our meta-analysis sug-
gests that there is no FADS2-breastfeeding interaction
(although such strong conclusion might not be feasible
due to sample size limitations).
Understanding the health effects—and associated
mechanisms—of breastfeeding is important to obtain a
more accurate view of the impact of breastfeeding pro-
motion. This, in turn, may have implications regarding
the extent to which investments on such promotion
should be prioritised over other public health initiatives.
Identifying the mechanisms could also be important to
incorporate key nutritional components of breast milk
into formula milk.
Regarding effect modiﬁcation (if any) of FADS2 var-
iants on the association between breastfeeding and IQ,
individual studies published to date are inconsistent.
Improving current understanding of this interaction
might yield biological insights regarding the importance
of LC-PUFAs for breastfeeding effects. This research
question will be addressed using a collaborative
meta-analysis based on consistent a priori deﬁned analysis
of harmonised data. Therefore, publishing this protocol
will reduce potential biases associated with data mining,
thus contributing to generation of reliable evidence.
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